Frequency News and Research

RSS

Experimental treatment for sickle cell disease enters Phase 3 clinical trials

An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute has entered Phase 3 clinical trials, David I. Meyer, PhD, LA BioMed president and CEO announced today.

26 Jul 2010

Preclinical data of new acamprosate prodrug to be presented at International Fragile X Conference

XenoPort, Inc. announced today that it has discovered a novel prodrug that has the potential to improve significantly the blood concentration of acamprosate compared with the currently approved formulation of acamprosate. Preclinical data on this new product candidate will be presented tomorrow at the National Fragile X Foundation's 12th International Fragile X Conference in Detroit, Michigan.

23 Jul 2010

Annual premium for employer sponsored family health plan costs 54% more in 2009 than in 2000: AHRQ

The annual premium for a family health plan sponsored by an employer cost about 54 percent more in 2009 than it did in 2000, $13,027 and $8,437 (adjusted for inflation), respectively, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

23 Jul 2010

Bullied children are at risk for developing emotional problems

Bullying victimization is common among children of school age, although its consequences are often anything but benign. The recent death of a Massachusetts teen by suicide prompted state lawmakers to pass one of the most far-reaching anti-bullying laws within the U.S. Whether such legislative actions result in measurable decreases in physical or emotional distress among school peers remains to be seen.

23 Jul 2010

Study: Americans with stand-alone vision insurance plans more likely to receive annual eye examination

According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).

21 Jul 2010

Affymetrix introduces Axiom Custom Genotyping Arrays

Affymetrix, Inc. today announced that it has launched Axiom™ Custom Genotyping Arrays, the newest addition to the Axiom Genotyping Solution. Researchers can now leverage Affymetrix' Axiom Genomic Database, the world's largest collection of validated common and rare SNPs, to create custom arrays containing 50,000 to as many as 2.6 million SNPs. This inherent flexibility allows researchers to conduct genome-wide association, replication, fine mapping, and candidate gene studies on a single platform.

21 Jul 2010

Mental exercises may help reverse age-related cognitive decline

Specialized brain training targeted at the regions of a rat's brain that process sound reversed many aspects of normal, age-related cognitive decline and improved the health of the brain cells, according to a new study from researchers at University of California, San Francisco.

21 Jul 2010

Active play is important for children’s physical activity

Active play makes a significant contribution to children’s physical activity and could play an important part in the health of future generations, a new study has found.

20 Jul 2010

Researchers use bioelectric signals of brain to detect neurodegenerative diseases

A group of researchers from Universidad Carlos III de Madrid has presented a new algorithm that uses a new method to analyse the information obtained from electroencephalograms to detect neurodegenerative diseases, such as epilepsy, using the bioelectric signals of the brain.

20 Jul 2010

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Kidney disease is a growing public health problem, with approximately half a million individuals in the United States requiring dialysis treatments to replace the function of their failed kidneys. The problem is particularly acute among African-Americans, whose rates of kidney disease are four times higher than those of European Americans.

20 Jul 2010

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research

A pneumococcal conjugate vaccine introduced in the U.S. 10 years ago appears to reduce pneumonia and serious associated complications, such as blood infections, in the vaccine's target range, children less than a year old, according to new research.

19 Jul 2010

Researchers compare impact of heat waves on mortality in different European cities

Heat waves may cause increased mortality but, until now, there has been no single scientific definition for the occasional bursts of hot weather that can strike during the summer months. Researchers writing in BioMed Central's open access journal Environmental Health have created a definition that they use to document, for the first time, how heat wave mortality impact differs between European cities.

16 Jul 2010

An overview of AAPM annual meeting

AAPM is the premier organization in medical physics, a broadly-based scientific and professional discipline encompassing physics principles and applications in medicine and biology. Its membership includes medical physicists who specialize in research that develops cutting-edge technologies and board-certified clinical medical physicists who apply these technologies in community hospitals, clinics, and academic medical centers.

16 Jul 2010

Physicists find clues to origin, evolution of wrinkles in thin sheets

As a sign of aging or in a suit, wrinkles are almost never welcome, but two papers in the current issue of Physical Review Letters offer some perspective on what determines their size and shape in soft materials.

16 Jul 2010

Research supports population screening for fragile X syndrome in women of reproductive age

There's adequate research data to support population screening of women of childbearing age for fragile X syndrome—the most common inherited cause of cognitive impairment, according to a report in the July issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

14 Jul 2010

Highlights of AAPM 52nd meeting

The 52nd meeting of the American Association of Physicists in Medicine (AAPM) convenes from July 18 - 22, 2010 in Philadelphia, PA.

14 Jul 2010

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not been established.

12 Jul 2010

Study results show cognitive decline significantly lower among regular tea drinkers

Results of a new study found people age 65 or older who drank tea regularly had 17-37% less cognitive decline compared with people who did not drink tea. The new findings were presented here at the Alzheimer's Association's International Conference on Alzheimer's Disease 2010.

12 Jul 2010

Simple interventions by pediatricians change parent's perspective about child being overweight or obese

Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.

12 Jul 2010

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Biogen Idec and Swedish Orphan Biovitrum AB today announced results from a Phase 1/2a open-label, dose-escalation, safety and pharmacokinetic study of the companies' long-lasting, fully-recombinant factor IX Fc fusion protein (rFIXFc) in hemophilia B patients. The data, which were presented at the World Federation of Hemophilia Congress in Buenos Aires, Argentina, on July 11, 2010, showed that rFIXFc was well tolerated and demonstrated an approximately three-fold increase in half-life compared to historical data for existing therapies.

12 Jul 2010

Frequency News and Research

Experimental treatment for sickle cell disease enters Phase 3 clinical trials

Preclinical data of new acamprosate prodrug to be presented at International Fragile X Conference

Annual premium for employer sponsored family health plan costs 54% more in 2009 than in 2000: AHRQ

Bullied children are at risk for developing emotional problems

Study: Americans with stand-alone vision insurance plans more likely to receive annual eye examination

Affymetrix introduces Axiom Custom Genotyping Arrays

Mental exercises may help reverse age-related cognitive decline

Active play is important for children’s physical activity

Researchers use bioelectric signals of brain to detect neurodegenerative diseases

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research

Researchers compare impact of heat waves on mortality in different European cities

An overview of AAPM annual meeting

Physicists find clues to origin, evolution of wrinkles in thin sheets

Research supports population screening for fragile X syndrome in women of reproductive age

Highlights of AAPM 52nd meeting

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

Study results show cognitive decline significantly lower among regular tea drinkers

Simple interventions by pediatricians change parent's perspective about child being overweight or obese

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News